Skip to content
Disclosery

Paradigm Biocapital Advisors LP: LXEO position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Paradigm Biocapital Advisors LP on LXEO, newest first. How the timeline and the estimate are built.

Paradigm Biocapital Advisors LP held 4,175,382 LXEO shares at 2026-06-30 per its 13F-HR filed 2026-08-14.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 4,175,382 shares
    Change vs previous 13F -2,008,752 shares

    0.36% of the 13F portfolio, value $19,436,403.

    13F-HR 0001855655-26-000014 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 6,184,134 shares
    Change vs previous 13F +1,420,936 shares

    0.73% of the 13F portfolio, value $35,496,929.

    13F-HR 0001855655-26-000011 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 4,763,198 shares
    Change vs previous 13F not available

    1.27% of the 13F portfolio, value $47,298,556.

    13F-HR 0001855655-26-000003 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).